Patients with NASH show signs of chronic inflammation, such as a high circulating LPS concentration (Wigg et al., 2001), low phagocytic capacity of KCs (Iijima et al., 2007), and hyperactivation of the innate immune response (Sharifnia et al., 2015). The gene discussed is TBCE; the disease is metabolic dysfunction-associated steatohepatitis.